Literature DB >> 9594840

Management of patients with mild aortic stenosis undergoing coronary artery bypass grafting.

J W Tam1, R G Masters, I G Burwash, A D Mayhew, K L Chan.   

Abstract

BACKGROUND: The management of mild aortic stenosis during coronary artery bypass grafting remains controversial.
METHODS: We reviewed the medical records of consecutive patients between January 1, 1977, and December 31, 1994, to identify 51 patients with mild aortic stenosis who underwent isolated coronary artery bypass grafting (group A), and 19 patients with mild aortic stenosis who underwent combined coronary artery bypass grafting and aortic valve replacement (group B). Patients with more than moderate aortic regurgitation were excluded. Preoperative angiograms were reviewed to assess the severity of calcification and restricted mobility of the aortic cusps.
RESULTS: In group A there were 11 deaths and 8 subsequent aortic valve replacements; in group B there were 5 deaths and 3 prosthetic valve-related complications. There was no difference in event-free survival between the two groups after adjusting for the difference in age. Among group A patients, the initial transvalvular gradient (p = 0.0005) and aortic valvular calcification (p = 0.06) identified patients who demonstrated progression to severe aortic stenosis during follow-up.
CONCLUSIONS: Our data suggest that routine aortic valve replacement during coronary artery bypass grafting in patients with mild aortic stenosis is not indicated, but concomitant aortic valve replacement may be appropriate in patients with higher transvalvular gradients and calcified valves.

Entities:  

Mesh:

Year:  1998        PMID: 9594840     DOI: 10.1016/s0003-4975(98)00062-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

Review 1.  When is concomitant aortic valve replacement indicated in patients with mild to moderate stenosis undergoing coronary revascularization?

Authors:  A Marc Gillinov; Mario J Garcia
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

2.  [Multiple-valve disease].

Authors:  H R Zerkowski; M Preiß
Journal:  Z Kardiol       Date:  2001-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.